Development of oral immunomodulatory agents in the management of multiple sclerosis. Nicholas R, Giannetti P, Alsanousi A, Friede T, Muraro PA Drug Des Devel Ther. 2011; 5:255-74. Epub 2011 May 10. PMID: 21625416. Abstract CommentRecommendBookmarkWatch